CLEAR CELL ENDOMETRIAL CARCINOMA
Clinical trials for CLEAR CELL ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive endometrial cancer: drug combo targets obesity link
Disease control Recruiting nowThis early-stage trial is testing the safety of combining two drugs, atezolizumab and ONC201, for people with advanced or recurrent endometrial cancer. The study includes both obese and non-obese participants to see how body weight affects treatment. The goal is to find the best …
Matched conditions: CLEAR CELL ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
New drug targets 'Broken Brakes' in Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a drug called valemetostat in people with advanced solid tumors that have certain gene changes (like SMARCB1 or ARID1A). The drug aims to reactivate protective genes to slow or stop cancer growth. About 900 adults will take the drug daily for up to 2 years, with …
Matched conditions: CLEAR CELL ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 11, 2026 20:48 UTC